Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -1.97% | 73.51 | 1.0% | $1662.26m | |
| AMGN | Amgen, Inc. | -0.45% | 218.21 | 1.3% | $912.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 512.96 | 2.6% | $838.70m | |
| BIIB | Biogen, Inc. | 1.29% | 321.05 | 1.5% | $803.32m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.22% | 246.61 | 1.9% | $654.46m | |
| ILMN | Illumina, Inc. | 2.36% | 287.62 | 3.5% | $500.86m | |
| MRNA | Moderna, Inc. | -1.73% | 31.86 | 0.0% | $490.05m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.36% | 96.23 | 2.0% | $302.00m | |
| A | Agilent Technologies, Inc. | 2.14% | 78.33 | 1.6% | $228.79m | |
| INCY | Incyte Corp. | -1.07% | 86.81 | 2.5% | $215.18m | |
| EXAS | EXACT Sciences Corp. | 1.04% | 67.06 | 21.0% | $180.99m | |
| SGEN | Seattle Genetics, Inc. | 0.54% | 120.32 | 6.1% | $157.23m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.06% | 79.55 | 4.3% | $148.36m | |
| IMMU | Immunomedics, Inc. | 6.57% | 19.64 | 11.9% | $133.04m | |
| NVAX | Novavax, Inc. | -0.76% | 17.05 | 114.7% | $128.79m |
Company Profile
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.